Keywords: novartis, build, first, cell, culture-derived, flu, vaccine

Novartis to build first cell culture-derived flu vaccine plant in USA

Article | 24 July 2006

Switzerland-headquartered pharmaceutical giant Novartis has announced plans to build what it says will be the first cell culture-derived influenza manufacturing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing